Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.
Published November 29, 2023 · Recall initiated: October 27, 2023
Summary
FDA records drug Class III recall D-0113-2024, published November 29, 2023 and initiated October 27, 2023. Recalling firm: NCS Healthcare of Kentucky Inc; Status: Terminated; Reported quantity: 1,344 cards; Lot: Lot#: a) 7718-3008, Exp 08/31/2024; b) 7718-3008, Exp 08/31/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
What to do
Voluntary: Firm initiated · Letter
Get an email if BUSPIRONE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUSPIRONE HYDROCHLORIDE
- Manufacturer
- NCS Healthcare of Kentucky Inc
- Distributor
- Nationwide USA
- Lot
- Lot#: a) 7718-3008, Exp 08/31/2024; b) 7718-3008, Exp 08/31/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAbusPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by Unichem LaboratoriesMay 13, 2026
- FDALisinopril Tablets USP 20 mg, packaged in a) 15-count blister card (NDC 0615-7718-05), b) 30-count blisterNovember 29, 2023
- FDAEsomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30;November 29, 2023
- FDAIntegrity Biochem HSC 70-VA, Alcohol Antiseptic 70%, Hand Sanitizer, Vanilla Scented Topical Gel 208.19L (55November 29, 2023
- FDABusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwindMay 3, 2023
- FDABusPIRone Hydrochloride Tablets USP, 5 mg, Rx Only, Packaged as: a) 100 Tablets NDC 16729-200-01 UPC 3 16729March 8, 2023
Questions about this recall
Was Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141. recalled?
Yes. FDA published recall D-0113-2024 on November 29, 2023. Reported hazard: Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUSPIRONE HYDROCHLORIDE.